NCI | Technology Transfer

Preparation Of 3, 4-dihydroquinolin-2(1H)-one Compounds As Inhibitors Or Modulators Of Artemis Endonuclease For The Treatment Of Cancer

Read more about Preparation Of 3, 4-dihydroquinolin-2(1H)-one Compounds As Inhibitors Or Modulators Of Artemis Endonuclease For The Treatment Of Cancer

US Application 63/759,935
Filed on 2025-02-18

Chimeric Antigen Receptors Containing Glypican 2 Binding Domains

Read more about Chimeric Antigen Receptors Containing Glypican 2 Binding Domains

China
202510522686.9
Filed on 2020-07-17

Reverse Thiazine Kinase Inhibitors

Read more about Reverse Thiazine Kinase Inhibitors

Patent Cooperation Treaty
PCT/US2025/037257
Filed on 2025-07-11

QUANTITATIVE PARTICLE IDENTIFICATION DIGITAL AUTORADIOGRAPHY

Read more about QUANTITATIVE PARTICLE IDENTIFICATION DIGITAL AUTORADIOGRAPHY

Patent Cooperation Treaty
PCT/US2025/028714
Filed on 2025-05-09

CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS

Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS

China
202510544999.4
Filed on 2025-04-28

BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE

Read more about BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE

South Korea
2025-7022506
Filed on 2025-07-04

FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF

Read more about FATTY ACID AND CYCLIZED DERIVATIVES OF THE IMMUNOMODULATORY PEPTIDE RP-182 WITH IMPROVED ANTI-TUMOR ACTIVITY, COMPOSITIONS, AND METHODS OF USE THEREOF

Patent Cooperation Treaty
PCT/US2025/032497
Filed on 2025-06-05

IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OF CANCER AND MYELOID-MEDIATED DISEASES

Read more about IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OF CANCER AND MYELOID-MEDIATED DISEASES

European Patent
23821436.5
Filed on 2025-06-06

IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OF CANCER AND MYELOID-MEDIATED DISEASES

Read more about IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OF CANCER AND MYELOID-MEDIATED DISEASES

US Application 19/126,866
Filed on 2025-05-02

NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

China
202510520314.2
Filed on 2025-04-24

Subscribe to NCI